What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Gene
- Disease
His primary areas of investigation include Multiple sclerosis, Immunology, Pathology, Myelin and Remyelination.
His Multiple sclerosis study combines topics in areas such as Surgery, Internal medicine, Epidemiology and Pediatrics.
Immunology and Central nervous system are commonly linked in his work.
As part of one scientific family, Moses Rodriguez deals mainly with the area of Pathology, narrowing it down to issues related to the Microglia, and often Cytokine.
His studies deal with areas such as Lesion and Spinal cord as well as Myelin.
In his research on the topic of Remyelination, Antigen and Molecular biology is strongly related with Monoclonal antibody.
His most cited work include:
- Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. (2596 citations)
- A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. (656 citations)
- Distinct Patterns of Multiple Sclerosis Pathology Indicates Heterogeneity in Pathogenesis (634 citations)
What are the main themes of his work throughout his whole career to date?
Moses Rodriguez spends much of his time researching Multiple sclerosis, Immunology, Remyelination, Virus and Central nervous system.
The various areas that Moses Rodriguez examines in his Multiple sclerosis study include Myelin, Oligodendrocyte, Neuroscience and Pathology.
His study in Immunology concentrates on Immune system, Antibody, Monoclonal antibody, Antigen and CD8.
His Virus research incorporates themes from Inflammation and Encephalomyelitis.
His Central nervous system study combines topics in areas such as Central nervous system disease and Spinal cord.
The various areas that Moses Rodriguez examines in his Virology study include Transgene, Picornavirus, Major histocompatibility complex and Theilovirus.
He most often published in these fields:
- Multiple sclerosis (49.07%)
- Immunology (44.18%)
- Remyelination (19.56%)
What were the highlights of his more recent work (between 2013-2021)?
- Multiple sclerosis (49.07%)
- Immunology (44.18%)
- Internal medicine (8.43%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Multiple sclerosis, Immunology, Internal medicine, Remyelination and Pediatrics.
The Multiple sclerosis study which covers Pathology that intersects with Spinal cord.
His Internal medicine research includes themes of Gastroenterology, Endocrinology and Clinically isolated syndrome.
Moses Rodriguez has researched Remyelination in several fields, including Axonal loss, Aptamer and Disease.
His research in Demyelinating disease intersects with topics in Microglia and Demyelinating Disorder.
His studies deal with areas such as Virus, Virology, Antibody and Antigen as well as Immune system.
Between 2013 and 2021, his most popular works were:
- Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls (383 citations)
- Multiple Sclerosis and Related Disorders (195 citations)
- Human Gut-Derived Commensal Bacteria Suppress CNS Inflammatory and Demyelinating Disease (96 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Disease
His scientific interests lie mostly in Multiple sclerosis, Immunology, Internal medicine, Pediatrics and Clinically isolated syndrome.
Particularly relevant to Demyelinating disease is his body of work in Multiple sclerosis.
Immunology is frequently linked to Neuroprotection in his study.
His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology, Endocrinology and Surgery.
His Pediatrics research incorporates elements of Not Otherwise Specified, Acute disseminated encephalomyelitis and Neuromyelitis optica.
His work deals with themes such as Axon, Disease and Serotonin, which intersect with Remyelination.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
